SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-081218
Filing Date
2015-03-06
Accepted
2015-03-06 17:06:10
Documents
3
Period of Report
2015-03-05
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d885751d8k.htm 8-K 22671
2 EX-99.1 d885751dex991.htm EX-99.1 8657
3 EX-99.2 d885751dex992.htm EX-99.2 10304
  Complete submission text file 0001193125-15-081218.txt   43013
Mailing Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8
Business Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8 011-353-1-649-8521
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 15682485
SIC: 2834 Pharmaceutical Preparations